Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, TransMedics Group's Enterprise Value is €2,435.5 Mil.
TransMedics Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was €91.9 Mil. Therefore, TransMedics Group's EV-to-EBIT ratio for today is 26.51.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, TransMedics Group's Enterprise Value is €2,435.5 Mil.
TransMedics Group's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was €120.2 Mil. Therefore, TransMedics Group's EV-to-EBITDA ratio for today is 20.27.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, TransMedics Group's Enterprise Value is €2,435.5 Mil.
TransMedics Group's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was €546.7 Mil. Therefore, TransMedics Group's EV-to-Revenue ratio for today is 4.45.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
TransMedics Group (HAM:8T8) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
TransMedics Group's current Enterprise Value is €2,435.5 Mil.
TransMedics Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €91.9 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
TransMedics Group's current Enterprise Value is €2,435.5 Mil.
TransMedics Group's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €120.2 Mil.
TransMedics Group's current Enterprise Value is €2,435.5 Mil.
TransMedics Group's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €546.7 Mil.
TransMedics Group's current Enterprise Value is €2,435.5 Mil.
TransMedics Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €189.4 Mil.
TransMedics Group's current Enterprise Value is €2,435.5 Mil.
TransMedics Group's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €130.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TransMedics Group Enterprise Value Related Terms
TransMedics Group Enterprise Value Historical Data
* Premium members only.
The historical data trend for TransMedics Group's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HAM:8T8 vs AXGN, BFLY, ESTA: Enterprise Value Comparison
For the Medical Devices subindustry, TransMedics Group's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TransMedics Group Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, TransMedics Group's Enterprise Value distribution charts can be found below:
* The bar in red indicates where TransMedics Group's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
TransMedics Group's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of €2,435.5 Mil mean?
TransMedics Group (HAM:8T8) has a Enterprise Value of €2,435.5 Mil as of Jun. 29, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on TransMedics Group and its competitors.
Is TransMedics Group's Enterprise Value too high?
TransMedics Group's current Enterprise Value is €2,435.5 Mil. Overall, TransMedics Group has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does TransMedics Group's Enterprise Value compare to AXGN and BFLY?
TransMedics Group's Enterprise Value of €2,435.5 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on TransMedics Group and its competitors. TransMedics Group's current Enterprise Value is €2,435.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TransMedics Group stock overvalued right now?
TransMedics Group (HAM:8T8) has a current Enterprise Value of €2,435.5 Mil. The stock's GF Value™ is €162.08, compared to a current price of €66.68 — trading 58.9% below its estimated fair value. The current Enterprise Value is €2,435.5 Mil. TransMedics Group's overall GF Score™ is 69/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For TransMedics Group (HAM:8T8), the current Enterprise Value is €2,435.5 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TransMedics Group (HAM:8T8) Overvalued in 2026?
Based on GuruFocus' analysis, TransMedics Group stock appears to be undervalued.
The current stock price of €66.68 is trading 58.9% below its estimated GF Value™ of €162.08.
Key valuation signals for HAM:8T8:
Enterprise Value: €2,435.5 Mil
GF Value™: €162.08 vs. price of €66.68 (58.9% below fair value)
No single metric tells the full story. See the HAM:8T8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
69GF Score
Get the complete analysis for HAM:8T8
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:8T8 has been successfully added to your 
